National Research (US:NRC)2024-10-25 21:04Financial Performance - Revenue for Q3 2024 was approximately $35.8 million, a decrease of 5.5% compared to $37.9 million in Q3 2023[2] - Earnings per diluted share were $0.24, down from $0.32 in the same quarter last year, representing a decline of 25%[2] - Net income for Q3 2024 was $5.7 million, compared to $7.9 million in Q3 2023, reflecting a decrease of 27.7%[6] - Total operating expenses for Q3 2024 were approximately $27.8 million, slightly down from $28.0 million in Q3 2023[6] Shareholder Returns - The company returned approximately $11.5 million to shareholders through dividends and stock repurchases during the quarter[3] - The regular quarterly dividend of $0.12 per share was declared, amounting to approximately $2.9 million[3] Contract Value and Debt - Total recurring contract value (TRCV) reached approximately $131.6 million as of September 30, 2024[2] - The company's net indebtedness was approximately $50.2 million as of September 30, 2024[2] Assets and Equity - Total assets increased to $131.8 million from $122.4 million at the end of 2023[7] - Shareholders' equity decreased to $34.6 million from $49.0 million at the end of 2023[7]